Paradigm Biocapital Advisors »

Autolus Therapeutics Plc spon ads shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $81M 13M 6.44
2023-09-30 $34M 14M 2.33
2023-06-30 $22M 9.2M 2.38

More positions owned by Paradigm Biocapital Advisors

Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Legend Biotech Corp Sponsored Ads (LEGN)
Olema Pharmaceuticals (OLMA)
Miragen Therapeutics (VRDN)
Immunocore Hldgs Ads (IMCR)
Cerevel Therapeutics Hldng I (CERE)
Xenon Pharmaceuticals (XENE)
Mirati Therapeutics
Crinetics Pharmaceuticals In (CRNX)
Autolus Therapeutics Spon Ads (AUTL)
Bicycle Therapeutics Sponsored Ads (BCYC)
Ambrx Biopharma Call Option

View all positions for Paradigm Biocapital Advisors

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads